LABORATORIO FARMAC.ERFO (RK7) — Net Asset Quality Index
LABORATORIO FARMAC.ERFO (RK7) has a Net Asset Quality Index of 71.7% as of June 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €10.52 Million minus total liabilities of €2.98 Million yields net assets of €7.54 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read RK7 total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
LABORATORIO FARMAC.ERFO Net Asset Quality Index Over Time (2021–2023)
This chart shows how LABORATORIO FARMAC.ERFO's Net Asset Quality Index has evolved across 3 annual periods from 2021 to 2023. As of June 2024, the index stands at 71.7%, representing net assets of €7.54 Million against total assets of €10.52 Million EUR. For live market cap and overall valuation, see RK7 market cap.
Annual Net Asset Quality Index for LABORATORIO FARMAC.ERFO (2021–2023)
The table below presents the year-by-year Net Asset Quality Index for LABORATORIO FARMAC.ERFO from 2021 to 2023, covering 3 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See LABORATORIO FARMAC.ERFO shareholders equity for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 77.7% | €7.88 Million | €10.15 Million | €2.26 Million | ▲ +77.7 pp |
| 2022 | 0.0% | €0.00 | €10.53 Million | €10.53 Million | ▼ -68.2 pp |
| 2021 | 68.2% | €4.73 Million | €6.93 Million | €2.21 Million | — |